News | Robotic Systems | May 28, 2020

Hoag Performs First Robotic Carotid Artery Stenting on West Coast

Robotic surgery makes carotid stent placement safer and more precise 

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

Christopher Baker, M.D., and his team perpare to perform their first robotically navigated carotid artery stenting procedure at Hoag Memorial Hospital Presbyterian. The Corindus Corpath robotic system can be seen over the patient on the table.

May 28, 2020 — Hoag Memorial Hospital Presbyterian recently became the first hospital on the West Coast to perform an innovative robotic interventional procedure to stent a blockage in the carotid artery and improving blood flow to the brain. 

Christopher Baker, M.D., performs a robotically navigated carotid stenting procedure at  Hoag Memorial Hospital Presbyterian using a Corindus Corpath robotic system.Christopher Baker, M.D., director of interventional neuroradiology at the Pickup Family Neurosciences Institute at Hoag, implanted the stent using a new robotic tool, the CorPath GRX from Corindus, a Siemens Healthineers company. The robot helps physicians guide a wire, stent and balloon through a small incision in the patient’s arm or leg, and up into the patient’s neck artery to place the stent precisely at the site of blockage. This exact placement of the stent also allows less exposure to radiation for both the patient and the physician.

“CorPath is remarkable because I am able to perform a high precision, complex surgery while not being next to the patient,” Baker said. “The use of this technology means a safer, more precise surgery for the patient.”  

Thanks to donor support, Hoag’s Pickup Family Neurosciences Institute is the first site on the West Coast to perform robotic-assisted carotid stenting. Currently, robots are only FDA cleared for use in certain general surgery procedures and in peripheral vascular and interventional cardiology procedures. Baker said the tool will likely also prove invaluable in neuro-endovascular procedures. “Carotid stenting has been around for many years, but the really exciting part is the new ability to improve patient safety through precise control of the micro-tools we use in the arteries supplying the patient’s brain.”
 
As a founding member of Orange County’s designated Comprehensive Stroke Receiving Centers, Hoag’s Neurosciences team helped pioneer many of the advanced processes and specialized methods to optimize outcomes for stroke patients including prevention and reversal of acute stroke.
 
Hoag has also been designated a Center of Excellence in Robotic Surgery (COERS) by the Surgical Review Corp., which recognizes hospitals and surgeons who demonstrate an exceptional commitment and ability to consistently deliver safe, effective, evidence-based care through robotic surgery. 
 
“We are excited to be one of the first to offer this innovative robotic tool to help treat patients with significant carotid artery stenosis,” Baker said. “One cannot overstate how precision robotic-assisted tools improve outcomes and speed recovery for patients undergoing complex, very delicate surgeries and help us save more lives.”     

Related Cardiology Robotic System Content:

VIDEO: Standardizing PCI Through Smart Robotic Procedural Automation

Final Results of the Multicenter PRECISION GRX Study of the CorPath in a real-world population across a spectrum of lesion complexity — SCAI 2021 late-breaker

First-in-Human Telerobotic Coronary Intervention Procedures Published in EClinicalMedicine

Robocath Successfully Carries Out First Robotic Coronary Angioplasties in Humans

Corindus Vascular Robotics to Be Acquired by Siemens Healthineers

Corindus CorPath GRX Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019

 

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

VIDEO: Virtual Tour of the Robotic Electrophysiology Lab at Banner Health

Reducing Physician Radiation Dose With Robotics

Corindus Seeking Neurovascular Intervention Clearance for CorPath GRX Vascular Robotic System

Corindus CorPath Used in World's First-in-Human Telerobotic Coronary Intervention

 

Robots in the Cath Lab

VIDEO: First Robotic PCI Case in Germany With Robocath R-One System

Find more information on robotic systems for the cath and EP labs

Related Content

Feature | Cath Lab | September 14, 2021 | By Aaron Detate and Lars Thording
In the electrophysiology (EP) lab, hundreds
An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

An example of the Medis QCA angiography imaging derived fractional flow reserve (FFR) assessment. This technology removes the need for pressure wires and adenosine used in traditional FFR assessments of the coronary arteries.

News | Cath Lab | July 22, 2021
July 22, 2021 — Medis Medical Imaging is partnering with CORRIB Core Lab and Sinomed in randomized clinical trial of
ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.
News | Cath Lab | July 14, 2021
July 13, 2021 — East End Medical announced it received U.S.
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone. #SCAI21 #SCAI2021 Creating a card0-renal program.

There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal function are being excluded from interventional procedures because they are automatically considered too high risk. However, some hospitals are also creating cardio-renal care teams so these patients can be cared for by a team of experts rather than interventional cardiologists going it alone.

Feature | Cath Lab | May 14, 2021 | By Dave Fornell, Editor
There is a trend in interventional cardiology that is now being called “renalism,” where patients with poor renal fun
Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting proc

Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has gained European CE marked. This first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.

News | Cath Lab | May 12, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has
SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI heart attack. #SCAI21 #SCAI2021

SCAI 2021 late-breaking presentations included the data on the Medtronic Harmony transcatheter pulmonary valve, cutting radial access hemostasis time by 50 percent, improving cardiogenic shock survival to 71 percent, and data showing very high mortality in COVID patients who suffer a STEMI.

Feature | Cath Lab | May 06, 2021 | By Dave Fornell, Editor
April 29, 2021 — Here is the list of late-breaking study presentations and links to articles about each of them from
Most Stable Ischemic Heart Disease Patients Did Not Meet ISCHEMIA Trial Enrollment Criteria, raising questions about its application in real-world practice. #SCAI2021 Getty Images

Getty Images

News | Cath Lab | May 03, 2021
May 3, 2021 – Results from a new study find a broad range of patients who typically undergo revascularization for sta
New study demonstrates depression, HIV, mental health, obesity, alcohol and drug abuse are risk factors on most common type of heart disease in young black patients. Photo by Dave Fornell
News | Cath Lab | April 29, 2021
April 29, 2021 – A retrospective analysis of risk factors for coronary artery disease (CAD) in young African American
There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

There are far fewer patients coming to hospitals with heart attacks during the COVID-19 pandemic as compared to averages prior to the pandemic. This has raised concerns that delayed treatment will cause an uptick in cardiac deaths and heart failure. Photo from Getty Images 

News | Cath Lab | April 28, 2021
April 28, 2021 – Results from a retrospective observational study, presented today at...